
Seprix T 250mg/31.25mg Injection
Marketer
Sepik Life Sciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Seprix T 250mg/31.25mg Injection
Combiflox T Injection (250mg/31.25mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby halting infection progression. Administration must be strictly under medical guidance. Adherence to the prescribed schedule is crucial; complete the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms to your physician promptly. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Uses of Seprix T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Seprix T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Seprix T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Seprix T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Seprix T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Seprix T 250mg/31.25mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. The beta-lactamase inhibitor, Tazobactum, counters bacterial resistance mechanisms, optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Seprix T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Seprix T (250mg/31.25mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Administering Seprix T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Seprix T 250mg/31.25mg Injection may induce drowsiness, blurred vision, and dizziness. Driving is inadvisable if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Seprix T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Seprix T 250mg/31.25mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Seprix T 250mg/31.25mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Seprix T 250mg/31.25mg Injection :
Should you forget a scheduled dose of Seprix T 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Seprix T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
